CHEK2 LR variants (p.I157T, p.S428F, and p.T476M) appear to be more penetrant for any cancer, multiple primary cancers, breast cancer, and bilateral breast cancer when combined with a CHEK2 PV. Here, CHEK2 is linked to breast cancer.